Staar Surgical (STAA) | Stock Overview & Key Data
Staar Surgical Performance Comparison
Stock Range
Today's Range
Low: $27.75
High: $28.12
on August 21, 2025
52 Week Range
Low: $13.50
High: $38.60
on February 12, 2025
on September 30, 2024
All-Time High: $163.08 on September 6, 2021
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$1.4B
EPS
-1.93
P/E Ratio (TTM)
49.73
Forward P/E
35.39
P/B Ratio
4.09
PEG Ratio
-0.15
Div. Yield
N/A
ROE
-25.55%
Beta
0.618
Debt to Equity
12.04
Financial Highlights
Profitability
Gross Margin
74.00%
Operating Margin
-55.63%
Profit Margin
-42.45%
Returns and Earnings
Return on Assets (TTM)
-10.71%
Return on Equity (TTM)
-25.55%
EBITDA
$-73.0M
Net Income (TTM)
$-95.3M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$4.55
Quarterly Revenue Growth (YoY)
-55.20%
Quarterly Earnings Growth (YoY)
-55.23%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Staar Surgical STAA | 1.39B Small-cap | -2.80% | 56.36% | 50.51% | 64.61% | 15.23% | -16.53% | -71.80% | -39.17% |
| Intuitive Surgical ISRG | 171.78B Large-cap | -1.51% | -8.96% | -14.11% | -20.60% | -10.33% | -3.43% | 122.60% | 93.89% |
| Becton, Dickinson BDX | 56.27B Large-cap | 0.84% | 12.15% | 13.57% | -13.54% | -13.18% | -16.82% | -22.50% | -16.99% |
| AtriCure ATRC | 1.76B Small-cap | 0.90% | 22.20% | 7.43% | -6.93% | 17.53% | 40.45% | -24.04% | -15.97% |
| Azenta AZTA | 1.41B Small-cap | -2.45% | -4.73% | 8.59% | -33.32% | -40.37% | -39.40% | -46.75% | -42.97% |
| Biolife Solutions BLFS | 1.17B Small-cap | -0.95% | 20.81% | 13.54% | -5.96% | -4.20% | -0.87% | 8.62% | 17.64% |
Ownership & Short Interest
Insider Ownership
0.56%
Institutional Ownership
111.02%
Shares Short
6M
Short Ratio
9.86
Short % of Shares Outstanding
29.02%
Average 10-Day Volume
2M
Average 90-Day Volume
2M
Staar Surgical Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Staar Surgical would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is STAA's 52-week high and low?
- In the last 52 weeks, Staar Surgical reached a high of $38.60 (on September 30, 2024) and a low of $13.50 (on February 12, 2025).
- What is the market cap and P/E ratio for STAA?
- Curious about Staar Surgical's size and valuation? Its market capitalization stands at 1.39B. When it comes to valuation, the P/E ratio (trailing twelve months) is 49.73, and the forward P/E (looking ahead) is 35.39.
- Does STAA pay dividends? If so, what's the yield?
- As for dividends, Staar Surgical isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Staar Surgical's main competitors or similar companies to consider before investing?
When looking at Staar Surgical, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Intuitive Surgical
ISRG171.78B Healthcare Medical Instruments & Supplies -3.43% 122.60% Becton, Dickinson
BDX56.27B Healthcare Medical Instruments & Supplies -16.82% -22.50% AtriCure
ATRC1.76B Healthcare Medical Instruments & Supplies 40.45% -24.04% Azenta
AZTA1.41B Healthcare Medical Instruments & Supplies -39.40% -46.75% Biolife Solutions
BLFS1.17B Healthcare Medical Instruments & Supplies -0.87% 8.62% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Staar Surgical Company? (e.g., ROE, Debt/Equity)
- To get a sense of Staar Surgical's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -25.55%, the Debt to Equity ratio from the most recent quarter is 12.04, and its Gross Profit Margin stands at 74.00%.
- What is the recent revenue and earnings growth for STAA?
- Looking at Staar Surgical's growth, its revenue over the trailing twelve months (TTM) was $224M. Compared to the same quarter last year (YoY), quarterly revenue grew by -55.20%, and quarterly earnings saw a YoY growth of -55.23%.
- How much of STAA stock is held by insiders and institutions?
- Wondering who owns Staar Surgical stock? Company insiders (like executives and directors) hold about 0.56% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 111.02%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.